TickerFacts.

Perspective Therapeutics, Inc. (CATX): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2022-06-30, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$6.18M
Year ended 2022-06-30
+13.1%
3-year compound annual growth
+9.5%
5-year compound annual growth
+3.5%
10-year compound annual growth
2011-06-30: $4.08M2012-06-30: $4.37M2013-06-30: $4.38M2014-06-30: $4.42M2015-06-30: $4.44M2016-06-30: $4.64M2017-06-30: $3.92M2018-06-30: $4.08M2019-06-30: $4.27M2020-06-30: $4.56M2021-06-30: $4.93M2022-06-30: $6.18M$6.18M
2011-06-30 Cost of Revenue (USD) 2022-06-30
Period endedCost of RevenueChange YoYSource filing
2022-06-30$6.18M+25.3%2022-09-28, From 2021-07-01
2021-06-30$4.93M+8.3%2022-09-28, From 2020-07-01
2020-06-30$4.56M+6.8%2022-09-28, From 2019-07-01
2019-06-30$4.27M+4.6%2021-09-27, From 2018-07-01
2018-06-30$4.08M+4.0%2020-09-25, From 2017-07-01
2017-06-30$3.92M-15.5%2019-09-27, From 2016-07-01
2016-06-30$4.64M+4.5%2018-09-26, From 2015-07-01
2015-06-30$4.44M+0.5%2017-09-28, From 2014-07-01
2014-06-30$4.42M+0.9%2016-09-09, From 2013-07-01
2013-06-30$4.38M+0.2%2015-09-14, From 2012-07-01
2012-06-30$4.37M+7.0%2013-09-30, From 2011-07-01
2011-06-30$4.08Mn/a2012-10-26, From 2010-07-01